BioCryst Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone. My name is Gena Wang. I'm (inaudible) biotech analyst at Barclays. Welcome to our Annual Global Healthcare Conference in Miami. It is my great pleasure to introduce our next presenting company, BioCryst. With us today, we have Jon Stonehouse, President and CEO of BioCryst. We also have Charlie Gayer, Chief Commercial Officer.
Before I dive into specific questions, maybe Jon, you wanted to give a brief overview about BioCryst.
Sure. Well, first off, thank you for inviting us to your conference this year. It's good to be here in Miami. Charlie and I are both going to be making some forward-looking statements and those statements at risk, and you can find our risk factors on our website.
Yes. I think we're in a unique position as a biotech company, especially in a pretty challenging environment. We have product on the market that's been off to a spectacular
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
